Global Uveitis Treatment Market Survey and Trend Research 2018

June 2018 | 82 pages | ID: GDA70326981EN
99Strategy

Abstracts

Summary

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Novartis, Valeant Pharmaceutical International, EyeGate Pharmaceuticals, Alimera Sciences, Bausch & Lomb Incorporated, Bausch & Lomb Incorporated, AbbVie, Allergan, Amdipharm Mercury Company, pSivida Corp etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Uveitis Treatment Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 UVEITIS TREATMENT MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Novartis (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Valeant Pharmaceutical International (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 EyeGate Pharmaceuticals (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Alimera Sciences (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Bausch & Lomb Incorporated (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Bausch & Lomb Incorporated (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 AbbVie (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Allergan (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Amdipharm Mercury Company (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 pSivida Corp (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

TABLE GLOBAL UVEITIS TREATMENT MARKET 2012-2017, BY TYPE, IN USD MILLION

Table Global Uveitis Treatment Market 2012-2017, by Type, in Volume
Table Global Uveitis Treatment Market Forecast 2018-2023, by Type, in USD Million
Table Global Uveitis Treatment Market Forecast 2018-2023, by Type, in Volume
Table Novartis Overview List
Table Uveitis Treatment Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Valeant Pharmaceutical International Overview List
Table Uveitis Treatment Business Operation of Valeant Pharmaceutical International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table EyeGate Pharmaceuticals Overview List
Table Uveitis Treatment Business Operation of EyeGate Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Alimera Sciences Overview List
Table Uveitis Treatment Business Operation of Alimera Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bausch & Lomb Incorporated Overview List
Table Uveitis Treatment Business Operation of Bausch & Lomb Incorporated (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bausch & Lomb Incorporated Overview List
Table Uveitis Treatment Business Operation of Bausch & Lomb Incorporated (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AbbVie Overview List
Table Uveitis Treatment Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Allergan Overview List
Table Uveitis Treatment Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amdipharm Mercury Company Overview List
Table Uveitis Treatment Business Operation of Amdipharm Mercury Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table pSivida Corp Overview List
Table Uveitis Treatment Business Operation of pSivida Corp (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Uveitis Treatment Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Uveitis Treatment Sales Revenue Share, by Companies, in USD Million
Table Global Uveitis Treatment Sales Volume 2012-2017, by Companies, in Volume
Table Global Uveitis Treatment Sales Revenue Share, by Companies in 2017, in Volume
Table Uveitis Treatment Demand 2012-2017, by Application, in USD Million
Table Uveitis Treatment Demand 2012-2017, by Application, in Volume
Table Uveitis Treatment Demand Forecast 2018-2023, by Application, in USD Million
Table Uveitis Treatment Demand Forecast 2018-2023, by Application, in Volume
Table Global Uveitis Treatment Market 2012-2017, by Region, in USD Million
Table Global Uveitis Treatment Market 2012-2017, by Region, in Volume
Table Uveitis Treatment Market Forecast 2018-2023, by Region, in USD Million
Table Uveitis Treatment Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Uveitis Treatment Industry Chain Structure
Figure Global Uveitis Treatment Market Growth 2012-2017, by Type, in USD Million
Figure Global Uveitis Treatment Market Growth 2012-2017, by Type, in Volume
Figure Global Uveitis Treatment Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Uveitis Treatment Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region